Soluble CD27 (sCD27) has been detected in the cerebrospinal fluid (CSF) of patients with neuroinflammatory diseases [11–13] and described as a prognostic biomarker of MS in clinically isolated syndrome (CIS) [14] and childhood-acquired demyelinating syndromes [15]. The gene discussed is CD27; the disease is myeloid sarcoma.